Cart
sales@molnova.com
Fraxetin
CAS No. 574-84-5
Fraxetin( —— )
Catalog No. M15099 CAS No. 574-84-5
Extracted from Fraxinus brngeana DC.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 42 | In Stock |
|
| 5MG | 38 | In Stock |
|
| 10MG | 61 | In Stock |
|
| 25MG | 103 | In Stock |
|
| 50MG | 151 | In Stock |
|
| 100MG | 221 | In Stock |
|
| 200MG | 332 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFraxetin
-
NoteResearch use only, not for human use.
-
Brief DescriptionExtracted from Fraxinus brngeana DC.
-
DescriptionExtracted from Fraxinus brngeana DC.;Suitability:Alcohol and hydrochloric acid;Store the product in sealed,cool and dry condition.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number574-84-5
-
Formula Weight208.17
-
Molecular FormulaC10H8O5
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mM
-
SMILESO=C1C=CC2=C(O1)C(O)=C(O)C(OC)=C2
-
Chemical Name7,8-dihydroxy-6-methoxychromen-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang H, et al. Mol Med Rep. 2014 Nov;10(5):2341-5.
molnova catalog
related products
-
(D-2-Nal5,Cys6·11,Ty...
BIM 23042, a certain somatostatin (SS) octapeptide analogue, is a selective neuropeptide neuromedin B receptor (NMB-R, BB1) antagonist. BIM 23042 has 100-fold lower affinity for gastrin-releasing peptide (GRP) receptor (BB2). BIM 23042 inhibits Neuromedin?B?, ICI 216140 and DPDM-bombesin ethylamide-induced Ca2+ release.
-
BAY-3827 B
BAY-3827 is a potent and selective AMPK inhibitor with potential antitumor activity, demonstrating antiproliferative effects in an androgen-dependent prostate cancer model and inhibiting the phosphorylation of acetyl CoA carboxylase 1 (ACC-1).
-
5-(4-Chlorophenyl)-N...
5-(4-Chlorophenyl)-N-[[2-(2,2,2-trifluoroethoxy)pyridin-3-yl]methyl]pyridine-3-carboxamide is an inhibitor of human NaV1.8
